Prevention of organ rejection (kidney, liver, and heart);
Treatment of rheumatoid arthritis and psoriasis.
Therapeutic effects:
Suppresses the immune system to prevent organ rejection in transplant recipients.
Inhibits the activation of T-cells, a type of white blood cell involved in immune responses.
Interaction with other drugs:
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products.
Certain medications interact with Grafotas 100mg Capsule and reduce its effectiveness by causing undesirable side effects.
Safety advices:
Pregnancy: Discuss with your healthcare professional.
Breast feeding: Do not breastfeed while taking this medication.
Lungs: Inform your physician if you have any lung diseases before initiating the therapy.
Liver: Use cautiously in individuals with liver impairment or pre-existing liver disease.
Alcohol: It is unsafe to drink alcohol while taking Grafotas 100mg Capsule.
Driving: Avoid driving and operating heavy machinery during the treatment.
Side effects:
Serious: Kidney damage, liver damage, infection, fever or sore throat, lack of coordination, memory problems, difficulty in speaking, visual problems, seizures, confusion, personality changes, sleeplessness, agitation.
Common: Hypertension, electrolyte imbalance, increased level of potassium in the blood, tremor, abnormal hair growth, enlargement of gum tissues, low levels of magnesium, risk of infections, headache, gastrointestinal disturbances.
Word of advice:
Monitor infections, kidney and liver function, blood pressure, and neurological symptoms closely.
Abruptly stopping this medication can increase the risk of rejection in organ transplant patients or worsening autoimmune conditions.
Regular skin examinations and vigilance for signs of malignancies are advised.
Awareness of potential drug interactions and gastrointestinal side effects is crucial.
Regular blood tests to monitor blood cell counts and electrolyte levels are essential.
Pediatric and geriatric patients require special consideration.
Psychological effects should be monitored, and close consultation with healthcare professionals is necessary.
FAQs:
Can I consume grapefruit or grapefruit juice while taking Grafotas 100mg Capsule?
No, avoiding consuming grapefruit or grapefruit juice while taking Grafotas 100mg Capsule is generally advised.
Can I receive vaccinations while on Grafotas 100mg Capsule?
Vaccinations are generally safe and recommended. However, live vaccines may be contraindicated due to the immunosuppressive effects.
Can Grafotas 100mg Capsule cause kidney or liver damage?
Grafotas 100mg Capsule has the potential to cause kidney and liver damage. Regular monitoring of kidney and liver function is crucial.
How can I manage the increased blood pressure associated with Grafotas 100mg Capsule?
Regular monitoring of blood pressure is important. If your blood pressure increases significantly, your healthcare professional may recommend lifestyle modifications or medication.
Can I abruptly stop taking Grafotas 100mg Capsule?
Abruptly stopping Grafotas 100mg Capsule can increase the risk of organ rejection in transplant patients or worsening of autoimmune conditions.
What are the effects of Grafotas 100mg Capsule on blood?
Grafotas 100mg Capsule can affect blood cell counts, increasing the risk of infection, bleeding, and anemia. Regular blood tests should be conducted.
Can Grafotas 100mg Capsule cause diabetes?
Grafotas 100mg Capsule may lead to the development of new-onset diabetes mellitus or exacerbate existing diabetes. Regular monitoring of blood glucose levels is recommended.
Can Grafotas 100mg Capsule increase the risk of developing certain types of cancer?
Grafotas 100mg Capsule has been associated with an increased risk of developing certain types of cancer, particularly skin cancers and lymphomas. Regular skin examinations are recommended.
Fact box:
Molecule name: Cyclosporine
Therapeutic class: Immunosuppressants
Pharmacological class: Immunosuppressant agents
Indications:
Prevention of organ rejection (kidney, liver, and heart);